Corrin Drakulich is the Hiring Principal of the Atlanta office. She specializes in intellectual property litigation with an emphasis on patent litigation. Ms. Drakulich has successfully represented plaintiffs and defendants in patent cases spanning a wide range of technologies, including medical devices, biotechnology, pharmaceuticals, healthcare technology, turbocharger design, and manufacturing technology. Ms. Drakulich has also successfully represented clients in trademark and product liability litigations. She has substantial experience in all major aspects of litigation from pre-suit diligence through trial and post-trial, and also counsels clients on due diligence considerations and freedom to operate studies. Ms. Drakulich has been recognized by the Daily Report as one of 30 young lawyers “on the rise” and named a Rising Star in Intellectual Property Litigation by Super Lawyers.
Ms. Drakulich earned her Juris Doctor degree from the University of California at Berkeley (Boalt Hall), where she served as the Editor-in-Chief of the Berkeley Technology Law Journal, earned a Certificate of Specialization in Law & Technology, and was awarded the Boalt Moot Court Advocacy Award. Ms. Drakulich also served as a Judicial Extern for the Honorable Ronald D. Thom of the Fifth Judicial District of Oregon.
Ms. Drakulich graduated first in her class from the University of Georgia, receiving a Bachelor of Science degree in Microbiology and a Bachelor of Arts degree in Comparative Religion. She was awarded Academic All-American honors as a pole-vaulter on the University of Georgia track and field team and, upon graduating, was the 2004 recipient of the NCAA Walter Byers Postgraduate Scholarship (awarded to the top collegiate scholar-athlete in the country). Prior to attending law school, Ms. Drakulich held research positions at the Adang Laboratory and ViaGen, Inc. Swine and Cattle Cloning Company in Athens, Georgia.
Medigus Ltd. v. EndoChoice, Inc. (D. Del.) – Defending EndoChoice against Medigus’ assertion of a patent related to endoscopes.
EndoChoice, Inc. v. Medigus Ltd. and Medigus USA LLC (D. Del.) – Representing EndoChoice in enforcement of trademark rights related to endoscopy products.
Baxter International, Inc. v. Fresenius Medical Care (N.D. Ill.) – Defending Fresenius against Baxter’s assertion of patents related to peritoneal dialysis systems.
St. Jude Medical v. Volcano Corp. (D. Del.) –Defended Volcano against St. Jude’s assertion of a patent related to cardiac guidewire consoles. Case resulted in settlement favorable to client.
Allergan Sales, LLC v. Lupin Ltd. et al. and Consolidated Cases against Alcon, Apotex & Akorn (E.D. Tex.) – Represented Allergan in assertion of pharmaceutical patents related to ophthalmic non-steroidal anti-inflammatory drugs against generic manufacturers. All cases resulted in settlements favorable to client.
St. Jude Medical v. Volcano Corp. (D. Del.) – Defended Volcano in patent litigation and jury trial related to pressure sensing guide wires used to diagnose heart problems. At trial, jury found two St. Jude patents invalid, two not infringed; a fifth patent was declared not infringed by the court on the eve of trial.
BorgWarner, Inc. v. Honeywell Int’l, Inc. (W.D.N.C.) – Represented BorgWarner in assertion of patents relating to the design and manufacture of turbocharger components. Case resulted in settlement for $32.5 million to client.
Baxter Healthcare Corp. v. Fresenius Medical Care (N.D. Cal.) – Defended Fresenius against Baxter’s assertion of patents related to peritoneal dialysis systems. At trial, jury found Fresenius did not infringe Baxter’s patents.
Allergan, Inc., et al. v. Watson Laboratories, Inc. – Florida, et al. (D. Del.) – Represented Allergan, Endo Pharmaceuticals and Supernus Pharmaceuticals in assertion of pharmacological patents for treatment of overactive bladder against generic manufacturers.
Corbett Life Sciences v. Applied Biosystems, Inc. (N.D. Cal.) – Represented Applied Biosystems in assertion of realtime PCR instrument patent. Case resulted in settlement favorable to client.
Fluidigm Corporation v. Applied Biosystems, Inc. (S.D. N.Y.) – Represented Applied Biosystems in assertion of realtime PCR instrument patent. Case resulted in settlement favorable to client.